The relationship between Cardiac Autonomic Dysfunction and Glycemic Variability in Pediatric Patients with Type 1 Diabetes Mellitus
Article Sidebar
Main Article Content
Abstract
Objective: Objective: Cardiovascular autonomic neuropathy (CAN) is defined as the impairment of cardiovascular autonomic control in patients with diabetes mellitus (DM) after excluding other causes. This study aims to investigate the relationship between glycemic variability and CAN in pediatric patients with type 1 DM
Material and Methods: The study population consisted of children aged 8-18 who were being followed up with the diagnosis of type 1 DM. The diagnosis of CAN was made based on the heart rate variability indices and the results of the cardiovascular reflex tests..
Results: The study included 21 pediatric patients with type 1 diabetes mellitus (DM), consisting of 6 males and 15 females, with a median age of 13.94 years. Among them, 5 (23.8%) had early involvement, and 4 (19%) had definitive cardiovascular autonomic neuropathy (CAN). Patients with definitive CAN were significantly older and had a longer disease duration than those without CAN (p<0.05). Additionally, patients with definitive CAN had significantly higher hemoglobin A1c (HbA1c) levels (p<0.05). The time in the target blood glucose range (TIR) was significantly lower, while the time above the target blood glucose range (TAR) was significantly higher in patients with definitive CAN than in other patients (p<0.05). The standard deviation (SD) was also higher in patients with definitive CAN, but not significantly so (p>0.05).
Conclusion: The study's findings indicated that TIR, which is one of the glycemic variability parameters, was significantly lower and TAR was considerably higher in children with definitive CAN, and SD was higher, albeit not significantly, in children with definitive CAN. Nevertheless, large-scale, prospective cohort studies are needed to fully elucidate the relationship between CAN and glycemic variability in pediatric type 1 DM patients.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-02-20
Published 2023-02-20
References
Metwalley KA, Hamed SA, Farghaly HS. Cardiac autonomic function in children with type 1 diabetes. Eur J Pediatr. 2018;177(6):805-13.
Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al.; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-93.
Verrotti A, Loiacono G, Mohn A, Chiarelli F. New insights in diabetic autonomic neuropathy in children and adolescents. Eur J Endocrinol. 2009;161(6):811-8.
Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta- analysis. Diabetes Care. 2003;26(6):1895-901.
Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33(2):434-41.
Rasmussen VF, Jensen TS, Tankisi H, Karlsson P, Vestergaard ET, Kristensen K, et al. Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review. J Diabetes Complications. 2021;35(11):108027.
Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8(5):491-8.
Boysen A, Lewin MA, Hecker W, Leichter HE, Uhlemann F. Autonomic function testing in children and adolescents with diabetes mellitus. Pediatr Diabetes. 2007;8(5):261-4.
Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab. 2008;34:612-6.
Helleputte S, De Backer T, Lapauw B, Shadid S, Celie B, Van Eetvelde B, et al. The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: A systematic review. Diabetes Metab Res Rev. 2020;36(5):e3301.
Iwasaki S, Kozawa J, Fukui K, Iwahashi H, Imagawa A, Shimomura I. Coefficient of variation of R-R interval closely correlates with glycemic variability assessed by continuous glucose monitoring in insulin-depleted patients with type 1 diabetes. Diabetes Res Clin Pract. 2015;109(2):397-403.
Jaiswal M, McKeon K, Comment N, Henderson J, Swanson S, Plunkett C, et al. Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes. Diabetes Care. 2014;37(9):2616-21.
Jaiswal M, Ang L, Mizokami-Stout K, Pop-Busui R. Is there an association between non-dipping blood pressure and measures of glucose variability in type 1 diabetes? J Diabetes Complications. 2018;32(10):947-50.
Jun JE, Lee SE, Lee YB, Ahn JY, Kim G, Hur KY, et al. Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes. Diabetes Metab Res Rev.2018;35:e3092.
Nyiraty S, Pesei F, Orosz A, Coluzzi S, Vági OE, Lengyel C, et al. Cardiovascular Autonomic neuropathy and glucose variability in patients with type 1 diabetes: is there an association? Front Endocrinol. 2018;9(174):1-9.
Lachin JM, Bebu I, Bergenstal RM, Pop-Busui R, Service FJ, Zinman B, et al; DCCT/EDIC Research Group. Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complications trial. Diabetes Care. 2017;40(6):777-83.
Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer P, et al. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med. 1992;9(2):166-75.
Heart rate variability standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354-81.
Gąsior JS, Sacha J, Pawłowski M, Zieliński J, Jeleń PJ, Tomik A, et al. Normative values for heart rate variability parameters in school-aged children: simple approach considering differences in average heart rate. Front Physiol. 2018;24(9):1495.
Gardim CB, de Oliveira BA, Bernardo AF, Gomes RL, Pacagnelli FL, Lorençoni RM, et al. Heart rate variability in children with type 1 diabetes mellitus. Rev Paul Pediatr. 2014;32(2):279-85.
Chessa M, Butera G, Lanza GA, Bossone E, Delogu A, De Rosa G, et al. Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children. Herz. 2002;27(8):785-90.
Young RJ, Ewing DJ, Clarke BF. Nerve function and metabolic control in teenage diabetics. Diabetes. 1983;32(2):142-7.
Verrotti A, Chiarelli F, Blasetti A, Morgese G. Autonomic neuropathy in diabetic children. J Paediatr Child Health. 1995;31(6):545-8.
Jaiswal M, Divers J, Urbina EM, Dabelea D, Bell RA, Pettitt DJ, et al.; SEARCH for Diabetes in Youth Study Group. Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study. Pediatr Diabetes. 2018;19(4):680-9.
Kardelen F, Akçurin G, Ertug H, Akcurin S, Bircan I. Heart rate variability and circadian variations in type 1 diabetes mellitus. Pediatr Diabetes. 2006;7:45-50.
Chen SR, Lee YJ, Chiu HW, Jeng C. Impact of glycemic control, disease duration, and exercise on heart rate variability in children with type 1 diabetes mellitus. J Formos Med Assoc. 2007;106:935-42.
Bjornstad P, Dart A, Donaghue KC, Dost A, Feldman EL, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1432-50.
Silva TP, Rolim LC, Sallum Filho C, Zimmermann LM, Malerbi F, Dib SA. Association between severity of hypoglycemia and loss of heart rate variability in patients with type 1 diabetes mellitus. Diabetes Metab Res Rev. 2017;33(2):10-17.
Horvath EM, Benko R, Kiss L, Murányi M, Pék T, Fekete K, et al. Rapid "glycaemic swings" induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia. 2009;52(5):952-61.
Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57:1349-54.
Maeda M, Hayashi T, Mizuno N, Hattori Y, Kuzuya M. Intermittent high glucose implements stress-induced senescence in human vascular endothelial cells: role of superoxide production by NADPH oxidase. PLoS One. 2015;10(4):14.
Hjortkjær HØ, Jensen T, Hilsted J, Mogensen UM, Corinth H, Rossing P, et al. Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathy. J Diabetes Complications. 2019;33(2):171-7.
Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-87.
Robinson RT, Harris ND, Ireland RH, Macdonald IA, Heller SR. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes. Diabetologia. 2004;47(2):312-5.